Creatinine Level | SARS-CoV | |||||
---|---|---|---|---|---|---|

At d 0 (n=214) | At d 7 (n=139) | At d 30 (n=85) | At d 90 (n=70) | P value^{a}^{,}^{b} | P value^{c} | |

Median (IQR) | 140 (114–196) | 99 (68–191) | 75 (57–108) | 75 (63–103) | <0.001^{a} | |

No AKI/AKD/CKD, n (%) | 0 (0) | 94 (67.6) | 67 (77.9) | 58 (82.9) | <0.001^{b} | 0.17^{c} |

AKI stage 1, n (%) | 177 (82.7) | 19 (13.7) | AKD 19 (22.1) | CKD 12 (17.1) | ||

AKI stage 2, n (%) | 17 (7.9) | 3 (2.2) | ||||

AKI stage 3, n (%) | 20 (9.3) | 23 (16.5) | ||||

Creatinine Level | SARS-CoV-2 | |||||

At d 0 (n=66) | At d 7 (n=65) | At d 30 (n=63) | At d 90 (n=63) | P value^{a}^{,}^{b} | P value^{c} | |

Median (IQR) | 108 (91–129) | 83 (69–103) | 75 (67–97) | 75 (66–94) | <0.001^{a} | |

No AKI/AKD/CKD, n (%) | 0 (0) | 55 (84.6) | 55 (87.3) | 58 (92.1) | <0.001^{b} | 0.20^{c} |

AKI stage 1, n (%) | 63 (95.5) | 3 (4.6) | AKD 8 (12.7) | CKD 5 (7.9) | ||

AKI stage 2, n (%) | 3 (4.5) | 1 (1.5) | ||||

AKI stage 3, n (%) | 0 (0) | 6 (9.2) | ||||

P value | 0.009^{d} | 0.005^{c} |

↵a Friedman test was used to compare creatinine level at d 0, 7, 30, and 90.

↵b Bhapkar test was used compare creatinine level and AKI status at d 0 and 7.

↵c Generalized estimating equations was used to compare presence of any AKI/AKD at d 7, 30, and 90.

↵d Categories of AKI/AKD between SARS-CoV and SARS-CoV-2 were compared by chi-squared test or Fisher’s exact test, as appropriate.